Back
Protalix BioTherapeutics Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
PLX
Protalix BioTherapeutics
Last Price:
$2.36
Seasonality Move:
9.38%
7 Day Trial
ALL ACCESS PASS
$
7

Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing slight buying pressure.
Protalix BioTherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.49 | Sell |
20-day SMA: | 2.43 | Sell |
50-day SMA: | 2.44 | Sell |
200-day SMA: | 1.6 | Buy |
8-day EMA: | 2.43 | Sell |
20-day EMA: | 2.44 | Sell |
50-day EMA: | 2.36 | Sell |
200-day EMA: | 1.85 | Buy |
Protalix BioTherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 41.24 | Sell |
Chaikin Money Flow: | -690437 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Protalix BioTherapeutics Technical Analysis
Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 2.28 while PLX 8-day simple moving average is 2.49, which is a Sell signal.
-
The stock price of PLX is 2.28 while Protalix BioTherapeutics 20-day SMA is 2.43, which makes it a Sell.
-
Protalix BioTherapeutics 50-day simple moving average is 2.44 while PLX share price is 2.28, making it a Sell technically.
-
PLX stock price is 2.28 and Protalix BioTherapeutics 200-day simple moving average is 1.60, creating a Buy signal.
PLX Technical Analysis vs Fundamental Analysis
Sell
34
Protalix BioTherapeutics (PLX)
is a Sell
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a SellThe current Protalix BioTherapeutics [PLX] share price is $2.28. The Score for PLX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
177.9M
Price in USD:
2.28
Share Volume:
1M
Protalix BioTherapeutics 52-Week Range
52-Week High:
2.76
52-Week Low:
0.82
Sell
34
Protalix BioTherapeutics (PLX)
is a Sell
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?The Protalix BioTherapeutics stock price is 2.28 USD today.
-
Will PLX stock go up or go down?Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protalix BioTherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is overvalued.
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 2.28 while PLX 8-day exponential moving average is 2.43, which is a Sell signal.
-
The stock price of PLX is 2.28 while Protalix BioTherapeutics 20-day EMA is 2.44, which makes it a Sell.
-
Protalix BioTherapeutics 50-day exponential moving average is 2.36 while PLX share price is 2.28, making it a Sell technically.
-
PLX stock price is 2.28 and Protalix BioTherapeutics 200-day simple moving average is 1.85, creating a Buy signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
-
PLX Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Protalix BioTherapeutics is a Buy
-
Protalix BioTherapeutics Relative Strength Index (RSI) is 41.24, which suggest Protalix BioTherapeutics is oversold
-
The Bollinger Bands (25) for Protalix BioTherapeutics is ( - ), which suggest Protalix BioTherapeutics is a Buy
-
The Bollinger Bands (100) for Protalix BioTherapeutics is ( - ), which suggest Protalix BioTherapeutics is a Buy
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.